106 Two additional clinical trials are being conducted to gather more data on adverse effects in different situations of liver injury, and a phase 2 trial investigating treatment effects for MASH with fibrosis based on histological assessment is ongoing (NCT05877547)
This was not Pfizers first or last oral GLP-1 disappointment
Researchers said weight regain has been reported after stopping other obesity medications, and overall data confirm the chronicity of obesity and highlight the importance of maintaining long-term pharmacological treatment for weight management in people with obesity. The success of GLP-1 medications can depend on how long people use them
Evaluation of spent mushroom substrate as substitute of peat in Chinese biobeds
William Seeds, MD, Founder of the International Peptide Society How to Get Started: Book a Peptide Consult At Saving Face, we take your health seriously
Coptis is the most concentrated natural source of berberine, which positively affects GLP-1 activation and improves metabolic health